Particle therapy is one of the most popular alternative treatment procedures for radiation therapy. With particle therapy systems, precise delivery of the radiation dose to the required tumor site is possible.Market growth is driven by factors such as growing adoption of particle therapy in clinical trials and the increasing number of particle therapy centers worldwide. Emerging markets are China India, Brazil, and South Africa are showing lucrative growth opportunities to market.

The particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027.

To know about the assumptions considered for the study download the pdf brochure

Key Market Players

Prominent players in the particle therapy market include Varian Medical Systems, Inc. (US), IBA Worldwide (EU), Mevion Medical Systems (US), Provision Healthcare, LLC (US), Sumitomo Heavy Industries, Ltd. (Japan), Hitachi, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), Protom International, Inc. (US), Advanced Oncotherapy PLC. (EU), and Danfysik A/S (Denmark)

IBA Worldwide (EU)

IBA is one of the leading players in the particle therapy market. Its Proton Therapy segment offers Proteus PLUS, a treatment room solution, and Proteus ONE, a single-room cancer treatment solution. IBA caters its products to various end users, including hospitals and ambulatory radiotherapy centers. The firm focuses on strengthening its market position by adopting both organic (such as product development and approvals) as well as inorganic growth strategies (such as agreements, collaborations, and partnerships). During the last three years, the company has significantly invested in R&D activities.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=12809137

Varian Medical Systems, Inc. (US)

Varian Medical Systems is one of the leading providers of particle therapy systems across the globe. The company offers excellent sales and support services, such as equipment installation and custom service. With its strong product portfolio and wide geographic presence, the company is expected to grow at a high rate in the proton therapy market. The company focuses on both organic and inorganic growth strategies to enhance its footprint in the global market. In the past three years, the company received approvals from various regulatory bodies to introduce its proton therapy products across various regions. The company is also focused on providing training and conducting workshops.

Recent Developments:

Varian Medical Systems, Inc. (US) partnership with Oncora Medical (US). This investment partnership was aimed at accelerating the development of software tools to enable precision medicine in radiation oncology.
IBA Worldwide (EU) partnership with Tractebel (US). This partnership agreement to support IBA’s customers with their proton therapy design and construction projects.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=12809137

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/particle-therapy-...
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/particle-therapy.asp